市場調查報告書
商品編碼
1492637
DVT 預防幫浦市場:按類型、最終用戶分類 - 2024-2030 年全球預測DVT Preventive Pump Market by Type (Intermittent Pneumatic Compression Devices, Sequential Compression Devices), End User (Hospitals & Clinics, Surgical Centers) - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年DVT預防幫浦市場規模為3.8306億美元,2024年將達4.0099億美元,預計2030年將達5.3258億美元,複合年成長率為4.81%。
DVT預防幫浦是一種預防深層靜脈栓塞症(DVT)的醫療設備。深層靜脈栓塞症是一種嚴重的疾病,血液凝塊在身體的深層靜脈(通常是腿部)中形成。這些血塊可能會產生嚴重後果,包括阻塞血流或破裂並到達肺部,導致稱為肺動脈栓塞的致命疾病。醫療保健提供者擴大向高風險患者推薦 DVT 預防措施,推動了 DVT 預防幫浦市場的成長。由於患者經常接受外科手術並長時間無法活動,因此對 DVT 預防設備的需求更大。 DVT 幫浦價格昂貴且有替代品,阻礙了市場成長。隨著 DVT 幫浦技術的創新(包括舒適性和易用性的改進)使該設備對醫療保健專業人員和患者都具有吸引力,預計會出現市場成長機會。
主要市場統計 | |
---|---|
基準年[2023] | 38306萬美元 |
預測年份 [2024] | 40099萬美元 |
預測年份 [2030] | 53258萬美元 |
複合年成長率(%) | 4.81% |
區域洞察
美洲的DVT預防幫浦市場高度發達,在臨床實務的採用率很高,特別是在美國、巴西和加拿大。該地區醫療衛生基礎設施發達,DVT防治意識較高,經濟穩定成長。市場成長是由手術相關的不動和肥胖的高發生率所推動的,這些都是 DVT 的危險因子。此外,醫療當局也制定了嚴格的指導方針,提倡使用血栓症預防設備。由於中國、印度和韓國等國家醫療產業的快速開拓,亞太地區是成長最快的地區。改善醫療基礎設施、增加醫療旅遊業以及導致 DVT 的文明病盛行率上升是該地區的主要驅動力。歐洲、中東和非洲地區呈現多樣化的市場場景。西歐國家(如北美)由於高醫療保健標準和支持採用 DVT 預防幫浦的監管政策而擁有穩固的市場影響。同時,受醫療基礎設施變化和 DVT 預防意識低下的影響,中東和非洲地區也出現了成長。然而,由於醫療保健設施的改善和政府針對醫療保健的舉措的增加,中東一些國家呈現出有希望的成長。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在 DVT 預防幫浦市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可對 DVT 預防幫浦市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該領域競爭性質的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對 DVT 預防幫浦市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[183 Pages Report] The DVT Preventive Pump Market size was estimated at USD 383.06 million in 2023 and expected to reach USD 400.99 million in 2024, at a CAGR 4.81% to reach USD 532.58 million by 2030.
A DVT preventive pump is a medical device designed to prevent deep vein thrombosis (DVT). Deep vein thrombosis is a serious condition where blood clots form in the deep veins of the body, commonly in the legs. These clots can have severe consequences, such as blocking blood flow or breaking off and traveling to the lungs, causing a potentially fatal condition known as pulmonary embolism. Increasing recommendations by healthcare providers for DVT preventive measures for at-risk patients contribute to the growth of the DVT preventive pumps market. The high number of surgical procedures, which often lead to prolonged periods of immobility, further drives the need for DVT preventive devices. The high cost of DVT pumps and the availability of certain alternatives hamper the market growth. Rising innovations in DVT pump technology, such as enhanced comfort and ease of use that make these devices more appealing to both healthcare providers and patients are expected to create opportunities for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 383.06 million |
Estimated Year [2024] | USD 400.99 million |
Forecast Year [2030] | USD 532.58 million |
CAGR (%) | 4.81% |
Regional Insights
The market for DVT preventive pumps in the Americas is highly developing, with a significant adoption rate in clinical settings, particularly in the United States, Brazil, and Canada. This region shows stable growth due to the well-established healthcare infrastructure and high awareness of preventive treatments for DVT. Factors contributing to the market growth include the high prevalence of surgery-related immobility and obesity which are risk factors for DVT. Additionally, there are strict guidelines from healthcare authorities promoting the use of thrombosis-prevention devices. The APAC region is experiencing the fastest growth in the DVT preventive pump market, which is attributed to the rapidly developing healthcare sectors in countries such as China, India, and South Korea. Improvements in healthcare infrastructure, rising medical tourism, and increasing prevalence of lifestyle diseases that predispose individuals to DVT are significant drivers in this region. The EMEA region presents a diverse market scenario. Western European countries display a robust market presence similar to North America due to high healthcare standards and regulatory policies that support the adoption of DVT preventive pumps. Conversely, the Middle East and Africa exhibit growth, influenced by variable healthcare infrastructure and lower awareness about DVT prevention. Nonetheless, some countries in the Middle East show promising growth due to improving healthcare facilities and increasing government initiatives focused on healthcare.
Market Insights
The market dynamics represent an ever-changing landscape of the DVT Preventive Pump Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the DVT Preventive Pump Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the DVT Preventive Pump Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
AIROS Medical Introduces Advanced AIROS 6P Compression Device for Comprehensive Lymphatic and Venous Treatment
AIROS Medical Inc. launched the AIROS 6P sequential compression device, complemented by specialized pants-like garments, designed to alleviate swelling in the abdomen, pelvis, and legs. This latest model, which follows the earlier release of the AIROS 8P, includes significant enhancements such as Peristaltic Mode functionality, which mimics natural wave-like muscle contractions, preferred for upper extremity treatments. The AIROS 6P, a 6-chamber pneumatic compression device, continues to be covered by Medicare and commercial insurers under HCPCS Code E0651, ensuring broad accessibility. [Published On: 2023-09-12]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the DVT Preventive Pump Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the DVT Preventive Pump Market, highlighting leading vendors and their innovative profiles. These include 3A Health Care S.R.L., Bio Compression Systems, Inc., Breg, Inc., Cardinal Health, Inc., Devon Medical Products, DJO Global, FlowAid Medical Technologies Corp., GE Healthcare, Huntleigh Healthcare Limited, Medline Industries, Inc., Medtronic PLC, Mego Afek ltd., NormaTec Industries LP, Oska Wellness, Smiths Medical, Stryker Corporation, SunTech Medical, Inc., Tactile Systems Technology Inc., Talley Group Limited, Vasomedical, Inc., and Zimmer Biomet.
Market Segmentation & Coverage